Bioventus (BVS) Interest Coverage Ratio (QoQ) (2020 - 2026)
Bioventus (BVS) Interest Coverage Ratio (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.61 Bn | 175.32 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.22 Bn | 99.00 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.29 Bn | 66.84 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn |
| 6 | Dexcom | 28.31 Bn | 27.19 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.03 Bn | 25.75 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 24.04 Bn | 20.91 Bn | 2.07 Bn |
| 10 | Bioventus | 828.42 Mn | 792.57 Mn | 90.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 1,021.60% |
| Dec 31, 2025 | -57.84% |
| Sep 27, 2025 | -33.45% |
| Jun 28, 2025 | -47.76% |
| Mar 29, 2025 | 2,383.58% |
| Dec 31, 2024 | 86.89% |
| Sep 28, 2024 | 111.59% |
| Jun 29, 2024 | -124.26% |
| Mar 30, 2024 | 10,239.91% |
| Dec 31, 2023 | -66.35% |
| Sep 30, 2023 | -64.18% |
| Jul 1, 2023 | 107.17% |
| Apr 1, 2023 | -335.22% |
| Dec 31, 2022 | 99.83% |
| Oct 1, 2022 | -3,753.20% |
| Jul 2, 2022 | 5.20% |
| Apr 2, 2022 | -1,658.86% |
| Dec 31, 2021 | -462.99% |
| Oct 2, 2021 | 51.56% |
| Jul 3, 2021 | -101.14% |